Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuya Minami

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Cancer Medicine|July 25, 2025
Anti-Angiogenic Agents for Advanced Hepatocellular Carcinoma Induce Liver AtrophyTaijiro Wake, Tomoharu Yamada, Ryosuke Tateishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 12, 2013
Spontaneous clearance of serum hepatitis C virus RNA during the clinical course of hepatocellular carcinoma in patients with chronic hepatitis CTatsuya Minami, Ryosuke Tateishi, Shuichiro Shiina, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 6, 2010
[Successful treatment of a gastrointestinal stromal tumor with liver metastases in a case that tolerated imatinib administration, by radiofrequency ablation using contrast-enhanced ultrasonography]Tatsuya Minami, Shinpei Sato, Yoshitaka Watanabe, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 10, 2021
Radiofrequency Ablation of Liver Tumors in Patients on Antithrombotic Therapy: A Case-Control Analysis of over 10,000 TreatmentsKoji Uchino, Ryosuke Tateishi, Taijiro Wake, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Impact of nucleos(t)ide analogues on the risk of hepatocellular carcinoma in chronic hepatitis B patients: a time-dependent Cox regression analysisMakoto Moriyama, Ryosuke Tateishi, Mizuki Nishibatake Kinoshita, et al.
Journal of Atherosclerosis and Thrombosis|December 5, 2017
Effects of a Dipeptidyl Peptidase 4 Inhibitor Sitagliptin on Glycemic Control and Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus (GLORIA Trial)Daisaku Masuda, Takuya Kobayashi, Masami Sairyou, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 3, 2026
Toward a Synthetic Data Revolution: Diffusion Model-Enhanced Hepatocellular Carcinoma Prediction in Steatotic Liver DiseaseMasaya Sato, Takuma Nakatsuka, Yuki Matsushita, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 1, 2025
Pre-Treatment Liver Stiffness Is a Stronger Predictor of Hepatocellular Carcinoma Development Than Post-Treatment Liver Stiffness After Hepatitis C Virus EradicationTakuma Nakatsuka, Ryo Nakagomi, Keisuke Mabuchi, et al.
Plos One|July 26, 2018
Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablationKoji Uchino, Ryosuke Tateishi, Ryo Nakagomi, et al.
Journal of Hepatology|October 19, 2018
Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapyMizuki Nishibatake Kinoshita, Tatsuya Minami, Ryosuke Tateishi, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Cancer Medicine|July 25, 2025
Anti-Angiogenic Agents for Advanced Hepatocellular Carcinoma Induce Liver AtrophyTaijiro Wake, Tomoharu Yamada, Ryosuke Tateishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 12, 2013
Spontaneous clearance of serum hepatitis C virus RNA during the clinical course of hepatocellular carcinoma in patients with chronic hepatitis CTatsuya Minami, Ryosuke Tateishi, Shuichiro Shiina, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 6, 2010
[Successful treatment of a gastrointestinal stromal tumor with liver metastases in a case that tolerated imatinib administration, by radiofrequency ablation using contrast-enhanced ultrasonography]Tatsuya Minami, Shinpei Sato, Yoshitaka Watanabe, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 10, 2021
Radiofrequency Ablation of Liver Tumors in Patients on Antithrombotic Therapy: A Case-Control Analysis of over 10,000 TreatmentsKoji Uchino, Ryosuke Tateishi, Taijiro Wake, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Impact of nucleos(t)ide analogues on the risk of hepatocellular carcinoma in chronic hepatitis B patients: a time-dependent Cox regression analysisMakoto Moriyama, Ryosuke Tateishi, Mizuki Nishibatake Kinoshita, et al.
Journal of Atherosclerosis and Thrombosis|December 5, 2017
Effects of a Dipeptidyl Peptidase 4 Inhibitor Sitagliptin on Glycemic Control and Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus (GLORIA Trial)Daisaku Masuda, Takuya Kobayashi, Masami Sairyou, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 3, 2026
Toward a Synthetic Data Revolution: Diffusion Model-Enhanced Hepatocellular Carcinoma Prediction in Steatotic Liver DiseaseMasaya Sato, Takuma Nakatsuka, Yuki Matsushita, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 1, 2025
Pre-Treatment Liver Stiffness Is a Stronger Predictor of Hepatocellular Carcinoma Development Than Post-Treatment Liver Stiffness After Hepatitis C Virus EradicationTakuma Nakatsuka, Ryo Nakagomi, Keisuke Mabuchi, et al.
Plos One|July 26, 2018
Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablationKoji Uchino, Ryosuke Tateishi, Ryo Nakagomi, et al.
Journal of Hepatology|October 19, 2018
Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapyMizuki Nishibatake Kinoshita, Tatsuya Minami, Ryosuke Tateishi, et al.
Pageof 7